Concepedia

Hema Sharma

HS

Statistics

Publications

6

Citations

193

H-Index

6

Active since

2016

Affiliations

Medicines for Malaria Venture(Current)

Imperial College London

Public Health England

Royal Free London NHS Foundation Trust

GlaxoSmithKline (United States)

Hema Sharma is an author at Medicines for Malaria Venture specializing in life sciences, infectious diseases, and bacterial infections.

ORCID

Publications per year

2016–2023

6

Publications

6

Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom

Hema Sharma, Debra S. Smith, Claire E. Turner et al. · Emerging infectious diseases · 2018 · 66 citations · Full text

, , +17

Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study

Inge Sutanto, Amin Soebandrio, Lenny L. Ekawati et al. · The Lancet Infectious Diseases · 2023 · 47 citations · Full text

, , +16

Ochromobactrum intermedium: an emerging opportunistic pathogen—case of recurrent bacteraemia associated with infective endocarditis in a haemodialysis patient

Tehmina Bharucha, Dinesh Sharma, Hema Sharma et al. · New Microbes and New Infections · 2016 · 31 citations · Full text

, , +17

Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection

Hema Sharma, Claire E. Turner, Matthew K. Siggins et al. · mSphere · 2019 · 18 citations · Full text

, , +17

Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial

Iván Darío Vélez, Tran Tinh Hien, Justin A. Green et al. · The Lancet Child & Adolescent Health · 2021 · 17 citations

, , +14

1–5 of 6